首页> 美国卫生研究院文献>Clinical Cardiology >Benefit of Anticoagulation Therapy in Hyperthyroidism‐Related Atrial Fibrillation

【2h】

Benefit of Anticoagulation Therapy in Hyperthyroidism‐Related Atrial Fibrillation

机译：抗凝治疗在甲亢相关心房颤动中的益处

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

期刊名称 Clinical Cardiology
作者
Pak‐Hei Chan; Jojo Hai; Chun‐Yip Yeung; Gregory Y.H. Lip; Karen Siu‐Ling Lam; Hung‐Fat Tse; Chung‐Wah Siu;
展开▼
作者单位

展开▼
年(卷),期 2015(38),8
年度 2015
页码 476–482
总页数 7
原文格式 PDF
正文语种
中图分类心血管疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Benefit of Anticoagulation Therapy in Hyperthyroidism‐Related Atrial Fibrillation [J] . Chan Pak‐Hei, Hai Jojo, Yeung Chun‐Yip, Clinical cardiology. . 2015,第8期

机译：抗凝治疗在甲亢相关心房颤动中的益处
2. Do Improvements in Anticoagulation Therapy Obviate the Need for Left Atrial Appendage Occlusion Therapies? Left Atrial Appendage Occlusion Addresses the Tremendous Unmet Needs of Stroke Prevention in Atrial Fibrillation That Persist Despite Recent Advances in Anticoagulation Therapy Response [J] . Ezekowitz Michael D., Kent Anthony P. Circulation: An Official Journal of the American Heart Association . 2014,第17期

机译：抗凝疗法的改进是否消除了对左心耳附件阻塞治疗的需要？左心耳附件阻塞解决了尽管未抗凝治疗反应的最新进展仍持续存在的房颤预防卒中预防的巨大需求。
3. Do Improvements in Anticoagulation Therapy Obviate the Need for Left Atrial Appendage Occlusion Therapies? Left Atrial Appendage Occlusion Addresses the Tremendous Unmet Needs of Stroke Prevention in Atrial Fibrillation That Persist Despite Recent Advances in Anticoagulation Therapy [J] . Whisenant Brian, Kar Saibal, Bunch T. Jared Circulation: An Official Journal of the American Heart Association . 2014,第17期

机译：抗凝疗法的改进是否消除了对左心耳附件阻塞治疗的需要？左心耳封堵解决了房颤中风预防的巨大未满足需求，尽管抗凝治疗最近取得了进展，但仍然存在
4. The Atrial Fibrillation Risk Score for Hyperthyroidism Patients [C] . Ilya V. Derevitskii, Daria A. Savitskaya, Alina Y. Babenko, International Conference on Computational Science . 2020

机译：甲亢患者的房颤风险评分
5. Early Identification and Intervention in Patients with Atrial Fibrillation Using an Implantable Cardiac Monitor to Significantly Improve Guideline-Based Anticoagulation Therapy in an Outpatient Cardiology Clinic [D] . Alvarez, Lisa 2019

机译：使用可植入式心脏监护仪对房颤患者的早期识别和干预，可显着改善门诊心脏病学诊所基于指南的抗凝治疗
6. Apixaban versus PhenpRocoumon: Oral AntiCoagulation plus antiplatelet tHerapy in patients with Acute Coronary Syndrome and Atrial Fibrillation (APPROACH-ACS-AF): Rationale and design of the prospective randomized parallel-group open-label blinded-endpoint superiority multicenter-trial of a triple therapy versus a dual therapy in patients with Atrial Fibrillation and Acute Coronary Syndrome undergoing coronary stenting [O] . Lisa Riesinger, Claudia Strobl, David M. Leistner, 2021

机译：Apixaban与苯procoumon：口服抗凝加抗血小板治疗急性冠状动脉综合征和心房颤动的患者（方法-ACS-AF）：理论和设计前瞻性随机平行开放标签盲 - 终点优势多中心试验对心房颤动患者的三重治疗与双重治疗和急性冠状动脉综合征接受冠状动脉抵抗
7. Benefit of Anticoagulation Therapy in Hyperthyroidism-Related Atrial Fibrillation [O] . Lip, GY, Yeung, CY, Hai, SHJJ, 2015

机译：甲状腺功能亢进相关心房颤动抗凝治疗的益处

Benefit of Anticoagulation Therapy in Hyperthyroidism‐Related Atrial Fibrillation

著录项

引文网络

相似文献

相关主题

期刊订阅